Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAukett Swanke Regulatory News (AUK)

  • There is currently no data for AUK

Trading Update

4 Nov 2019 07:00

RNS Number : 0483S
Aukett Swanke Group PLC
04 November 2019
 

 

Aukett Swanke Group plc

Trading Update and update regarding Aukett Swanke Moscow

Aukett Swanke Group Plc (the group) ("ASG"), the international group of architects, interior designers and associated engineering is pleased to provide the following trading update on performance to 30 September 2019.

The Board expressed the view that second half trading would be profitable and that this should result in recovering the first half loss to show a positive result at the year end. The Board is now pleased to be able to confirm that this remains the case and that the Group will achieve a profit for the full year to 30 September 2019, subject to there being no material impact for IFRS 9 and 15. Full year results will be reported in January 2020.

At the same time the Board can confirm that year end cash stood at £1,145,000 (2018: £710,000) and after deducting the Long Term Loan used to acquire Shankland Cox, Net Funds stood at £819,000 (2018: £157,000); a satisfactory improvement.

Trading in the new financial year has been stable though we remain vigilant regarding possible adverse impacts as a result the forthcoming General Election and prolonged Brexit negotiations.

Since the year end we have also sold the Group's subsidiary in Moscow, Aukett Swanke OOO ("AS Moscow"), having previously stated the Board's belief that AS Moscow would perform better under local ownership. Under the terms of a Sale Agreement AS Moscow was sold to Maxim Neretin, a Russian national, owner of Aurora Group (another Moscow based architectural practice) with whom the Group has previously co-operated on design projects, for a nominal consideration. The sale will result in inter-company loans being repaid to the Group and, under the terms of a licence arrangement, enables AS Moscow to continue to trade as Aukett Swanke, allowing the Group's brand to endure in this important market. The sale also safeguards our staffs' employment and was achieved without any warranties being provided to the new owner. AS Moscow made a loss of £17,000 in the year to 30 September 2018.

Commenting Nicholas Thompson, CEO, said:

"The recovery from the large loss in 2018 is a tribute to the perseverance of the staff in all of our operations and in the internal rigours of reducing cost during a difficult trading period.

The process to find a suitable successor to carry on the Russian business in our name has taken some considerable time to realise. Critically, the sale has safeguarded the interests of our staff in Moscow, avoids a costly closure process and provides some upside for shareholders through the ongoing licence arrangement. We are pleased with the outcome".

Enquiries

Aukett Swanke group Plc 020 7843 3000

Nicholas Thompson, Chief Executive Officer

Robert Fry, MD International

Tony Barkwith, Group Finance Director

 

finnCap 020 7220 0500

Corporate Finance: Julian Blunt/Giles Rolls

ECM: Alice lane

 

Investor /Media Enquiries 07979 604687

Chris Steele

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTFSLFMFFUSELF
Date   Source Headline
2nd Feb 20117:00 amRNSFinal Results
15th Nov 20102:37 pmRNSDirectorate Change
8th Oct 20107:00 amRNSTrading Update
17th Jun 20107:00 amRNSHalf Yearly Report
21st May 20107:00 amRNSNew contract
17th May 20107:00 amRNSTrading Statement
4th May 201012:34 pmRNSHolding(s) in Company
25th Mar 201010:20 amRNSResult of AGM
17th Mar 201011:22 amRNSDirector/PDMR Shareholding
24th Feb 20107:00 amRNSAnnual Financial Report
14th Jan 20107:00 amRNSFinal Results
21st Jul 20098:00 amRNSTrading Statement
8th Jul 20094:35 pmRNSFurther re recovery litigation
1st Jul 20097:00 amRNSDirectorate Change
18th Jun 20097:00 amRNSHalf Yearly Report
1st Jun 20098:41 amRNSChange of Registered Office
24th Apr 200911:04 amRNSTrading Statement
3rd Apr 20097:00 amRNSDirectorate Change
26th Mar 200910:53 amRNSAGM Statement
2nd Mar 20097:00 amRNSAnnual Report and Accounts
13th Feb 20097:00 amRNSTrading Statement
21st Jan 200912:18 pmRNSDividend Declaration
15th Jan 20097:00 amRNSFinal Results
23rd Oct 20087:00 amRNSTrading Update
23rd Jun 20085:16 pmRNSDividend Declaration
17th Jun 20087:00 amRNSInterim Results
2nd May 20087:00 amRNSDirectorate Change
21st Apr 200811:01 amRNSHolding(s) in Company
16th Apr 20083:08 pmRNSDirector/PDMR Shareholding
4th Apr 20084:04 pmRNSDirector/PDMR Shareholding
3rd Apr 20084:06 pmRNSDirector/PDMR Shareholding
27th Mar 200810:46 amRNSAGM Statement
29th Feb 200812:53 pmRNSAnnual Report and Accounts
15th Jan 20087:00 amRNSFinal Results
27th Nov 20077:00 amRNSTrading Update
5th Nov 20072:49 pmRNSDirector/PDMR Shareholding
12th Oct 20077:01 amRNSOffer Update
12th Oct 20077:00 amRNSEnd of Merger Discussions
2nd Oct 200711:55 amRNSRule 8.1- Aukett Fitzroy Robi
25th Sep 20074:47 pmRNSRule 8.1-Aukett Fitzroy Robin
25th Sep 20077:00 amRNSTrading Statement
19th Sep 200712:36 pmRNSRule 8.1-Aukett Fitzroy Robin
13th Sep 20071:56 pmRNSDividend Declaration
17th Aug 20073:11 pmRNSCompany Website
10th Aug 20073:47 pmRNSResult of EGM
8th Aug 200712:02 pmRNSPotential merger
8th Aug 200712:00 pmRNSMerger Discussions
8th Aug 20077:00 amRNSDirectorate Change
1st Aug 20077:00 amRNSChange of Adviser
18th Jul 20075:46 pmRNSNotice of EGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.